CN110343775A - The primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method - Google Patents
The primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method Download PDFInfo
- Publication number
- CN110343775A CN110343775A CN201910631817.1A CN201910631817A CN110343775A CN 110343775 A CN110343775 A CN 110343775A CN 201910631817 A CN201910631817 A CN 201910631817A CN 110343775 A CN110343775 A CN 110343775A
- Authority
- CN
- China
- Prior art keywords
- probe
- seq
- nucleotide sequence
- kit
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 title claims abstract description 81
- 238000001514 detection method Methods 0.000 title claims abstract description 58
- 241000224527 Trichomonas vaginalis Species 0.000 title claims abstract description 25
- 241000193830 Bacillus <bacterium> Species 0.000 title claims abstract description 24
- 238000003753 real-time PCR Methods 0.000 claims abstract description 17
- 230000003321 amplification Effects 0.000 claims description 27
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 27
- 239000002773 nucleotide Substances 0.000 claims description 22
- 125000003729 nucleotide group Chemical group 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 13
- 238000011529 RT qPCR Methods 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- 125000006853 reporter group Chemical group 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000013642 negative control Substances 0.000 claims description 10
- 238000010791 quenching Methods 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000013641 positive control Substances 0.000 claims description 9
- 230000000171 quenching effect Effects 0.000 claims description 9
- 239000013558 reference substance Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 3
- 239000007984 Tris EDTA buffer Substances 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000011010 flushing procedure Methods 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 244000000010 microbial pathogen Species 0.000 abstract description 2
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 13
- 206010046914 Vaginal infection Diseases 0.000 description 12
- 201000008100 Vaginitis Diseases 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 210000001215 vagina Anatomy 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000606153 Chlamydia trachomatis Species 0.000 description 6
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 6
- 241000701806 Human papillomavirus Species 0.000 description 6
- 241000204051 Mycoplasma genitalium Species 0.000 description 6
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 6
- 241000700584 Simplexvirus Species 0.000 description 6
- 229940038705 chlamydia trachomatis Drugs 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000222122 Candida albicans Species 0.000 description 5
- 241000204048 Mycoplasma hominis Species 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 230000001376 precipitating effect Effects 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 229960001631 carbomer Drugs 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 3
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 3
- 241000588650 Neisseria meningitidis Species 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000607762 Shigella flexneri Species 0.000 description 3
- 241001502500 Trichomonadida Species 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 208000037009 Vaginitis bacterial Diseases 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229960001699 ofloxacin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010037549 Purpura Diseases 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229940071110 amino-cerv Drugs 0.000 description 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 201000003146 cystitis Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- SRQKTCXJCCHINN-NYYWCZLTSA-N nifuratel Chemical compound O=C1OC(CSC)CN1\N=C\C1=CC=C([N+]([O-])=O)O1 SRQKTCXJCCHINN-NYYWCZLTSA-N 0.000 description 2
- 229960002136 nifuratel Drugs 0.000 description 2
- 229960000988 nystatin Drugs 0.000 description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 208000004483 Dyspareunia Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000207201 Gardnerella vaginalis Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 101150013707 HBB gene Proteins 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034531 Perinephric abscess Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000008921 jie er yin Substances 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 108010000849 leukocyte esterase Proteins 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Abstract
The present invention relates to the detection technique field of pathogenic microorganism more particularly to primer, probe groups, kit and the detection methods of double check Gardner bacillus and trichomonas vaginalis.It include GD/TV conservative region special primer pair and Taqman fluorescence probe in the kit, the kit passes through real-time fluorescence quantitative PCR, accurately GD/TV infection pattern detection can be come out, high sensitivity, specificity are good, repeated strong and convenient to use.
Description
Technical field
The present invention relates to the detection technique field of pathogenic microorganism more particularly to double check Gardner bacillus and vagina hairs
Primer, probe groups, kit and the detection method of trichomonad.
Background technique
Vaginitis (vaginitis) i.e. colpitis is to lead to vulvovaginal symptom such as itch, cusalgia, stimulation and exception
One group of illness of flow liquid.There are aerobic bacteria and anaerobic bacteria to reside in intravaginal under normal circumstances, forms normal vaginal flora.It is any
Reason breaks the ecological balance between vagina and flora, can also formation condition pathogenic bacteria.It is clinically common to have: bacterial vaginosis
Sick (occupying symptom women 22%~50%), monilial vaginitis (17%~39%), trichomonas vaginitis (4%~
35%), senile vahinitis, infantile vaginitis.The pathogen of vaginitis is effectively identified and diagnosed, for vaginitis
Symptomatic treatment it is most important.
The main pathogen of bacterial vaginosis BV (Bacterial vaginosis, BV) is vagina Gardner bacillus
(Gardnerella vaginalis, GD), can be through transmission through sex.Gardner bacillus is the tiny bacillus of Gram-negative, Chang Cheng
Club-shaped, sometimes in Filamentous and Multiple Shape, common bipolar staining.It is 0.4--0.6 microns wide, long 1--2 microns of size, non-activity
Power, atrichia, without gemma.Many bacterial strains have pod membrane.Infection caused by Gardner bacillus is most lighter, and the property be more common in enlivens woman
Female.Acute stage leucorrhea increasing has the stink of fish raw meat or ammonia, and vulva is moist uncomfortable, is often accompanied by vagina burning heat sensation, intercourse pain and vulva
It disturbs and itches.Inspection is shown in that some patientss vulva is red and swollen, and vagina mucosa is congested, is in bois de rose, and mild redness, secretion is in homogenieity more,
Thin, canescence is sometimes milk yellow or class green, bad smell.Vagina pH is often 5--5.5.Sometimes leukorrhea amount is few, only thin
It is one layer thin, it is covered on such as film sample on congested vaginal wall.Small number of patients vaginal wall has erythema or petechiae, and pregnant patient can cause to flow
Production or puerperal endometritis.Infection severe one may also lead to septicemia, urinary tract infection, perinephric abscess and cystitis etc..
Trichomonas vaginitis is common gynecological disease, is caused by trichomonas vaginalis (Trichomonas vaginalis).Hair drop
Worm is in wide pyriform or ellipse, and a length of 10~30 μm, 10~20 μm wide, there are 4 flagellums isometric with polypide on head, in microscope
Down it will be clear that this trichmonad.Trichmonad is very strong to different environment-adapting abilities, can be under the conditions of 25 DEG C~42 DEG C
Growth and breeding, 3 DEG C~5 DEG C of low temperature can survive 21 days, remain to existence 20~60 minutes at 46 DEG C, be detached from after human body half-dried
It can also survive a few hours under conditions of dry.Duration vaginitis is shown as after infection in women, onset can suddenly be delayed.Clinical manifestation is
Vaginal fluid increases, show bubble, bad smell taste, yellow green.Dysuria, pruritus vulvue.Acute stage is for 1 week or the several months,
State of an illness weight has fluctuation, dyspareunia, exacerbation of symptoms after the menstrual period.Subsequent leukorrhea is reduced, and symptom mitigates, and can also be completely disappeared.
If trichomonas vaginalis is parasitic in urethra or bladder, trichmonad property urethra, cystitis can be caused.Trichomonas vaginalis can swallow essence
Son can cause infertile.Trichomonas vaginalis can also cause cell development exception and dyskaryosis, and the incidence of cancer is significantly higher than nothing
Trichomonad women.Discovery is checked, from fornix vagina and cervix mild hyperaemia to extensive rotten to the corn, petechiae and crissum be rotten to the corn and flush
Endometrium (strawberry shape cervix).
Currently, the detection method of Gardner bacillus (GD), trichomonas vaginalis (Tv) property vaginitis (referred to as GD/Tv) is main
It is separately cultured, vaginitis five/seven and diagnosis of molecular biology, three kinds of methods have the following characteristics that
1) pathogen be separately cultured be GD/Tv goldstandard, but isolated culture is higher to technical requirements, and expense is relatively high
Expensive, time-consuming, using few in clinical detection.
2) vaginitis five-seven are current clinical detections using more laboratory method, predominantly detect vaginitis and draw
The index of correlation variation risen, including catalase, neuraminidase, leukocyte esterase, Prolyl iminopeptidase, acetylamino
Glucuroide, oxidizing ferment, pH value.But these indexs are indirect detection, have inexactness.
3) pathogen nucleic acid detects: have many advantages, such as that quick, accurate, detection window is short, highly sensitive, it can be to GD/Tv
Early diagnosis is made, provides strong technical support to the quick analysis and control of the state of an illness.
Wherein real-time quantitative PCR detection platform has become most simple and direct and reliable nucleic acid detection method, domestic and international at present
Diagnostic nucleic acid in be most widely used, testing principle is, detection probe be include 5 ' end reporter groups and 3 ' end quenching groups
Oligonucleotides, when probe is complete, due to quenching group close to reporter group greatly reduce reporter group sending it is glimmering
Light, when primer extend, the probe in conjunction with template is cut off by Taq enzyme (5 ' → 3 ' exonuclease activity), reporter group with quench
The group that goes out separation, generates fluorescence signal.In each PCR cycle, there is new reporter group to be sheared, therefore fluorescence signal is strong
The increase of degree and the quantity of amplified production are directly proportional, can monitor amplification situation in real time.
Currently, domestic be directed to vagina hair road trichomonad, there are the patent individually detected less than ten, Publication No.
The patent of CN102719529B discloses trichomonas vaginalis and Candida albicans binary channels fluorescence PCR detecting method and its reagent
Box is two re-detections for trichomonas vaginalis and Candida albicans;And it is directed to the fluorescence quantitative PCR detection pole of Gardner bacillus
Few, more without being directed to GD/Tv joint-detection PCR kit for fluorescence quantitative product.
Summary of the invention
In view of this, the technical problem to be solved in the present invention is that providing double check Gardner bacillus and trichomonas vaginalis
Primer, probe groups, kit and the detection method of Multiple detection, the targeted target fragment of the primer, probe groups is smaller, special
It is anisotropic stronger, and sensitivity is higher.
Primer, the probe groups of Gardner bacillus provided by the invention and trichomonas vaginalis Multiple detection comprising:
The primer pair of nucleotide sequence shown in NO:1~2 SEQ ID, the probe of nucleotide sequence shown in SEQ ID NO:3;
The primer pair of nucleotide sequence shown in NO:4~5 SEQ ID, the probe of nucleotide sequence shown in SEQ ID NO:6.
The present invention selects Gardner bacillus 16SrRNA conservative region, trichomonas vaginalis ITS conservative region, beta-globin base
Because of (HBB, internal standard) conservative region, specific primer and probe are designed, using Real-Time Fluorescent Quantitative PCR Technique, GD/Tv reality is made
When fluorescent quantificationally PCR detecting kit, and describe its application method.
In the present invention, the primer pair of nucleotide sequence shown in NO:1~2 SEQ ID, nucleotides sequence shown in SEQ ID NO:3
The probe of column is designed for the 16S sRNA of Gardner bacillus (GD), and the GD specific target gene fragment length is 127bp;Sequence
It is classified as: CGGATCGTAGTCTGCAACTCGACTACGTGAAGGCGGAGTCGCTAGTAATCGCGAAT CAGCAACGTCGCGGT
GAATGCGTTCCCGGGCCTTGTACACACCGCCCGTCAAGTCATGAAAGTGGGCAGCA(SEQ ID NO:10)。
In the present invention, the primer pair of nucleotide sequence shown in NO:4~5 SEQ ID, nucleotides sequence shown in SEQ ID NO:6
The probe of column is designed for the ITS of trichomonas vaginalis (Tv), and the Tv specific target gene fragment length is 153bp, sequence are as follows:
CAGGTTAATCTTTGAATGCAAATTGCGCTAAACTCGATCTCGGTCGAGAAGCATGGGTGTGACAGTACTACATCTT
TTATAATAATTCTTATTCTAAGCGAATAAGTAAATAATATATAAGACAAACAACACGTAGTCTGCCATACGCAGGAA
(SEQ ID No.11)。
Primer and probe of the present invention has good accuracy, sensitivity, specificity, even if in the same amplification
It is detected in system, it also being capable of good differentiation GD or Tv.This kit to the minimum detectability concentration of GD or Tv be 1.0 ×
100Copy/μ L, i.e. minimum detectability are 5 copies.
In the present invention, 5 ' ends of the probe are marked with fluorescent reporter group, and 3 ' ends are marked with fluorescent quenching group.
Specifically, 5 ' ends of the probe of nucleotide sequence shown in SEQ ID NO:3 are marked with fluorescent reporter group CY5,3 '
End is marked with fluorescent quenching group BHQ3;
5 ' ends of the probe of nucleotide sequence shown in SEQ ID NO:6 are marked with fluorescent reporter group FAM, and 3 ' ends are marked with
Fluorescent quenching group MGB.
The present invention also provides the kits of Gardner bacillus and trichomonas vaginalis Multiple detection comprising of the present invention
Primer, probe groups.
It further include the primer pair and probe to reference gene HBB detection in kit provided by the invention;
The nucleotide sequence of the primer pair for reference gene HBB detection is as shown in NO:7~8 SEQ ID;It is described
For reference gene HBB detection probe nucleotide sequence as shown in SEQ ID NO:9.The HBB specific target gene piece
Duan Xulie are as follows: TCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGG ATGAAGTTGGT
GGTGAGGCCCTGGGCAGGTTGGTATCAAGGTTACAAGACAGGTTTAAGGAGACCAATAGAAACTGGGCATG(SEQ
ID NO:12).In kit provided by the invention, 5 ' ends of the probe of nucleotide sequence shown in SEQ ID NO:12 are marked with glimmering
Light reporter group ROX, 3 ' ends are marked with fluorescent quenching group BHQ2.
It further include fluorescence quantitative PCR detection reagent and/or sample extraction reagent in kit provided by the invention;
The fluorescence quantitative PCR detection reagent includes qPCR Master Mix enzyme mixation, qPCR Master Mix anti-
Answer buffer;
The qPCR Master Mix enzyme mixation, including Taq enzyme and UNG enzyme, the Taq enzyme are AnstartTaq
Archaeal dna polymerase, the UNG enzyme are uracil-N-glycosylase.
The sample extraction reagent includes NaOH, TritonX-100 and TE buffer.
The sample extraction liquid includes NaOH final concentration of 0.01%~0.5%, and preferably 0.1%.
The sample extraction liquid includes TritonX-100 final concentration of 0.01%~0.5%, and preferably 0.1%.
It further include positive control and/or negative control in kit provided by the invention;
Negative controls of the invention are DEPC water;
Positive reference substance of the invention is the plasmid solution containing Gardner bacillus and trichomonas vaginalis target fragment.
The present invention also provides the methods for detecting and distinguishing Gardner bacillus and trichomonas vaginalis comprising: with the present invention
The kit carries out real-time fluorescence quantitative PCR detection to sample to be tested DNA, and it is then positive for generating S type amplification curve.
In method of the present invention, the system of the real-time fluorescence quantitative PCR includes:
Water complements to 25 μ L.
In system, the primer concentration is 100~1000nM, preferably 500nM.The concentration and probe concentration is 10~500nM,
Preferably 200nM.
In method of the present invention, the program of the real-time fluorescence quantitative PCR includes:
50 DEG C 2 minutes;
95 DEG C of 5 minutes initial denaturations;
95 DEG C 15 seconds → 60 DEG C 35 seconds, 45 circulation.
Judgement for result, specifically includes:
Value < 38 amplification curve Ct of measuring samples DNA and there is typical S type amplification curve, is positive findings;
The amplification curve Ct value of measuring samples DNA is equal to 45 (or being shown as Undet) or without typical S type amplification curve, is
Negative findings;
Value < 45 38≤Ct of amplification curve of DNA sample to be checked are gray area, and such as resurveying result still is value < 45 Ct, and
There is typical S type amplification curve, is then determined as positive findings;As Ct value is not shown still or without typical S type amplification curve, is then determined as
Negative findings.
In the case that measuring samples GD or Tv are feminine gender, investigating HBB amplification situation or HBB does not have S type amplification curve,
Or Ct value is greater than 35, shows sampling failure, extracts failure or sample-adding mistake, need to test again.
For the experiment of positive control is arranged, should also meet:, there is apparent expansion in positive control, the channel CY5 at the channel FAM
Increase, there is typical case's S type amplification curve, and Ct value is less than 30;
For be arranged negative control experiment, should also meet: negative control, the channel CY5, the channel FAM, value=45 Ct (or
It is shown as undet) or without typical S type amplification curve, subsequent judgement is carried out, it otherwise should carry out trouble-shoots.
Primer and probe of the present invention can be used for the detection of a variety of source samples.The detection of biological sample can be sentenced
Whether the sample break by GD or Tv infection, and may determine that the sample whether by GD or Tv pollution the detection of non-biological specimen.
Therefore, kit of the present invention can be used for the detection of the non-diagnostic purpose of sample.In the present invention, the sample of the detection comes
From vagina, medical instrument, drug, food or cosmetics.In some specific embodiments, the sample to be tested vaginal fluid.
Beneficial effects of the present invention include at least:
(1) invention is directed to the conservative region of GD/Tv/HBB, is total to specific designs 6 primers and 3 Taqman probes,
In conjunction with the conservative region of target gene, there is very high specificity, with pseudomonas aeruginosa strains CMCC10104, golden yellow
Aureus strains CMCC26001, Neisseria meningitidis strain CMCC29108, lactobacterium casei strains CMCC34103, large intestine angstrom are uncommon
Salmonella strain CMCC44103, deformed rod bacterial strain CMCC49102, bacterium typhosum strain CMCC50096, shigella flexneri strain
CMCC51573, Candida albicans bacterial strain CMCC98001, mycoplasma hominis (MH), herpes simplex virus (HSV), human papilloma virus
(HPV), human cytomegalovirus (HCMV), mycoplasma pneumoniae (MP), mycoplasma genitalium (MG), chlamydia trachomatis (CT), gonococcus
(NG), urea substance (UU) is without cross reaction;
(2) detection of 2 kinds of pathogens of GD/Tv is completed in same pipe, and is subject to area by different fluorescence labeling probes
Point, it can clinically be extracted by a sample nucleic acid, a nucleic acid sample-adding, complete the synchronous detection of 2 kinds of pathogens, be effectively reduced
Previous single tube detects the excessively high problem of bring testing cost, and is effectively improved the cumbersome situation of single tube detection;
(3) target gene segment is shorter, between 100~160bp, if the too short effect of depolluting that will affect UNG enzyme,
If too long will cause reaction efficiency decline, therefore the present invention can effectively avoid pollution and the high efficiency and spirit of reaction
Sensitivity can detect the GD/Tv DNA copied down to 5;
(4) human p-globin's gene-specific primer probe is added in reaction tube, it can effective monitoring specimen sample, sample
This extraction, PCR detect overall process, overcome and external standard is added in extraction process, be unable to the disadvantage of effective monitoring specimen sample success or not
End.
Kit of the invention is very suitable to clinical use and popularization, the prevention and control to GD/Tv in the women vaginitis in China
Work has great importance.
Detailed description of the invention
Fig. 1 is the fluorescence detection of 4 specificity experiments of embodiment as a result, the corresponding template of each detection curve is 1: verdigris is false single
Born of the same parents' bacteria strain CMCC10104,2: staphylococcus aureus strains CMCC26001,3: Neisseria meningitidis strain CMCC29108,4:
Lactobacterium casei strains CMCC34103,5: escherichia coli bacterial strain CMCC44103,6: deformed rod bacterial strain CMCC49102,7: typhoid fever
Salmonella strain CMCC50096,8: shigella flexneri strain CMCC51573,9: Candida albicans bacterial strain CMCC98001,10: human-like
Mycoplasma (MH), 11: herpes simplex virus (HSV), 12: human papilloma virus (HPV), 13: human cytomegalovirus (HCMV),
14: mycoplasma pneumoniae (MP), 15: mycoplasma genitalium (MG), 16: chlamydia trachomatis (CT), 17: gonococcus (NG), 18: urea substance
(UU) and 19: positive reference substance;
Fig. 2 is GD (channel the Cy5) fluorescence detection of 5 sensitivity experiment of embodiment as a result, the corresponding template of each detection curve
It is 1~7 for the plasmid solution containing GD/Tv/HBB target fragment, concentration is followed successively by 1.0 × 106、1.0×105、1.0×
104、1.0×103、1.0×102、1.0×101、1.0×100Copy/μ L;
Fig. 3 is Tv (channel the FAM) fluorescence detection of 5 sensitivity experiment of embodiment as a result, the corresponding template of each detection curve
It is 1~7 for the plasmid solution containing GD/Tv/HBB target fragment, concentration is followed successively by 1.0 × 106、1.0×105、1.0×
104、1.0×103、1.0×102、1.0×101、1.0×100Copy/μ L;
Fig. 4 is the fluorescence detection result of 100 times of positive control dilutions product (R1) of 6 repetitive test of embodiment.
Specific embodiment
The present invention provides the primer of Gardner bacillus and trichomonas vaginalis double check, probe, kit and detection sides
Method, those skilled in the art can use for reference present disclosure, be suitably modified realization of process parameters.In particular, it should be pointed out that all
Similar replacement and change is apparent to those skilled in the art, they are considered as being included in the present invention.This
The method of invention and application are described by preferred embodiment, and related personnel can obviously not depart from the present invention
Hold, in spirit and scope to methods herein and application is modified or appropriate changes and combinations, carrys out the implementation and application present invention
Technology.
The test material that the present invention uses is all common commercially available product, can all be bought in market.
Below with reference to embodiment, the present invention is further explained:
Embodiment 1: the present invention quickly detects the design of the primed probe pair of GD/Tv
Gardner bacillus 16SrRNA sequence, trichomonas vaginalis ITS sequence, HBB gene sequence in NCBI are downloaded, design is drawn
Object to and probe, sequence it is as follows:
The primer and probe sequence of the present invention of table 1
Embodiment 2: for quickly detecting the foundation of the real-time fluorescence quantitative PCR kit of GD/Tv
For quickly detecting the real-time fluorescence quantitative PCR kit of people GD/Tv, including reaction mixture, sample extraction liquid,
Positive reference substance, negative controls, specification and box body.
Wherein reaction mixture contains upstream and downstream primer and probe (NO:1~12 SEQ ID), Anstart qPCR
Master Mix enzyme mixation, Anstart qPCR Master Mix5 × reaction buffer.
Wherein Anstart qPCR Master Mix enzyme mixation, Anstart qPCR Master Mix5 × reaction are slow
Fliud flushing is provided by Fei Peng Biological Co., Ltd., and Anstart qPCR Master Mix enzyme mixation dilutes 25 times of uses,
Anstart qPCR Master Mix5 × reaction buffer dilutes 5 times of uses.
Wherein primer GD-F, GD-R, Tv-F, Tv-R, HBB-F, HBB-R final concentration 500nM.
Its middle probe GD-P, Tv-P, HBB-R concentration is 200nM.
Wherein GD-P fluorescence probe group is Cy5, and quencher BHQ3, Tv-P fluorescence probe group is FAM, quenches base
Group is MGB, and HBB-P fluorescence probe group is ROX, quencher BHQ2.
Wherein sample extraction liquid is the TE buffer containing 0.1%NaOH, 0.1%TritonX-100.
Wherein positive reference substance, for the plasmid solution containing GD/Tv/HBB target fragment, concentration is 10000 copies/μ
L, corresponding Ct value is 23 or so.
Wherein GD specific target gene fragment sequence are as follows:
CGGATCGTAGTCTGCAACTCGACTACGTGAAGGCGGAGTCGCTAGTAATCGCGAATCAGCAACGTCGC
GGTGAATGCGTTCCCGGGCCTTGTACACACCGCCCGTCAAGTCATGAAAGTGGGCAGCA(SEQ ID No.10)。
Wherein Tv specific target gene fragment sequence are as follows:
CAGGTTAATCTTTGAATGCAAATTGCGCTAAACTCGATCTCGGTCGAGAAGCATGGGTGTGACAGTAC
TACATCTTTTATAATAATTCTTATTCTAAGCGAATAAGTAAATAATATATAAGACAAACAACACGTAGTCTGCCAT
ACGCAGGAA(SEQ ID No.11)。
Wherein HBB specific target gene fragment sequence are as follows:
TCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG
GTGAGGCCCTGGGCAGGTTGGTATCAAGGTTACAAGACAGGTTTAAGGAGACCAATAGAAACTGGGCATG(SEQ ID
No.12)。
Wherein negative controls are DEPC water.
The rapid detection method of embodiment 3:GD/Tv kit for detecting nucleic acid
The GD/Tv in people's vaginal fluid is quickly detected using the kit of embodiment 2, the specific steps are as follows:
(1) it nucleic acid extraction: (determines whether to be felt by GD or Tv using cultivation to vaginal fluid (10 parts, number 1-10)
Dye, this method are current industry goldstandard) 1mL physiological saline, sufficiently oscillation washing cotton swab are added in collecting pipe, then by cotton
Swab extracts discarding by wall, and 500 μ L liquid is taken to be transferred in the centrifuge tube of 1.5mL, and 13000rpm is centrifuged 5 minutes, abandons supernatant, sinks
1mL physiological saline is added in shallow lake, breaks up precipitating, 13000rpm is centrifuged 5 minutes, is abandoned supernatant, is added in precipitating and has vibrated mixing
50 μ L of sample extraction liquid is vibrated in vortex oscillator and is broken up precipitating (gently breaing up precipitating with pipette tips when necessary), 100 DEG C of dry baths or
Person's water-bath 10 minutes, 13000rpm was centrifuged 5 minutes, and supernatant is for PCR reaction (without the precipitating of touch tube bottom when absorption
Object).
(2) real-time quantitative fluorescence PCR: PCR amplification is carried out using above-mentioned GD/Tv real-time fluorescence quantitative PCR detection kit
Reaction reacts mixing with kit respectively using the measuring samples DNA of extraction, positive control and each 5 μ L of negative control as template
20 μ L of liquid mixing carries out real-time fluorescence quantitative PCR reaction, the setting of PCR reaction condition are as follows: and 50 DEG C of 2 minutes UNG enzymes depollute, and 95
DEG C 5 minutes initial denaturations, 95 DEG C 15 seconds → 60 DEG C 35 seconds, the channel Cy5, FAM, ROX is for collecting detection fluorescence signal, and totally 45 are followed
Ring.
(3) result judges:
1. should meet: there is apparent amplification in positive control, the channel CY5, the channel FAM, have typical case's S type amplification curve,
And Ct value is less than 30;Negative control, the channel CY5, value=45 FAM channel C t (or being shown as undet) or bent without the amplification of typical S type
Line carries out subsequent judgement, otherwise should carry out trouble-shoots;
It is positive findings 2. value < 38 amplification curve Ct of measuring samples DNA and having typical S type amplification curve;
3. the amplification curve Ct value of measuring samples DNA is equal to 45 (or being shown as Undet) or without typical S type amplification curve,
For negative findings;
4. value < 45 38≤Ct of amplification curve of DNA sample to be checked are gray area, such as resurveying result still is value < 45 Ct,
And have typical S type amplification curve, then it is determined as positive findings;As Ct value is not shown still or without typical S type amplification curve, is then determined
For negative findings;
In the case that 5. measuring samples GD, Tv are feminine gender, investigating HBB amplification situation or HBB does not have S type amplification curve,
Or Ct value is greater than 35, shows sampling failure, extracts failure or sample-adding mistake, need to test again.
Determine result such as table 2:
2 sample detection result of table
The results show that 9 parts of GD positive sample, 1 part of Tv positive sample, wherein 1 part of full positive sample.As a result with the prior art
Identification is consistent, and accuracy rate is up to 100%.
Embodiment 4: specificity experiments
Using the method for kit, embodiment 3 in embodiment 2 respectively to pseudomonas aeruginosa strains CMCC10104, gold
Staphylococcus aureus bacterial strain CMCC26001, Neisseria meningitidis strain CMCC29108, lactobacterium casei strains CMCC34103, large intestine
Escherichia strain CMCC44103, deformed rod bacterial strain CMCC49102, bacterium typhosum strain CMCC50096, shigella flexneri
Strain CMCC51573, Candida albicans bacterial strain CMCC98001, mycoplasma hominis (MH), herpes simplex virus (HSV), human papilloma virus
Malicious (HPV), human cytomegalovirus (HCMV), mycoplasma pneumoniae (MP), mycoplasma genitalium (MG), chlamydia trachomatis (CT), leaching ball
Bacterium (NG), urea substance (UU) and positive reference substance carry out PCR detection, the result is shown in Figure 1, the results showed that, contain only GD/Tv target gene piece
The plasmid solution of section, i.e. positive reference substance are the positive, remaining pipe is feminine gender.The result shows that detection kit of the invention is special
It is anisotropic high, accurately, specifically GD/Tv can detected.
Embodiment 5: sensitivity experiment
Positive reference substance (i.e. the plasmid solution of the target fragment containing GD/Tv/HBB) is taken, its concentration is measured and calculates copy
Number is diluted according to 10 times of concentration gradients, chooses 1.0 × 100~1.0 × 106Copy/μ L concentration is as sample, with the present invention
Kit and detection method detected.
Testing result is as shown in Fig. 2-Fig. 3, the results showed that, this kit is 1.0 × 10 to the minimum detectability concentration of GD0
Copy/μ L (is equivalent to 100 bacterium/mL of concentration), i.e., minimum detectability is 5 copies.To the minimum detectability concentration of Tv be 1.0 ×
100Copy/μ L (is equivalent to 100/mL of concentration), i.e., minimum detectability is 5 copies.
Embodiment 6: repetitive test
100 times of dilution product for taking positive control in kit, are named as R1, with kit and detection method of the invention,
10 tests are continuously repeated, testing result is shown in Fig. 4, table 3, and the 100 of positive control times dilute the product GD value coefficient of variation as the result is shown
Respectively less than 5%.
The repeated reference plate Ct value of table 3 and the coefficient of variation (CV value).
Template | GD(CY5) | Tv(ROX) |
R1 | 31.79 | 32.18 |
R1 | 31.86 | 32.23 |
R1 | 31.86 | 31.98 |
R1 | 31.86 | 32.00 |
R1 | 31.59 | 32.08 |
R1 | 31.72 | 32.13 |
R1 | 31.95 | 32.44 |
R1 | 31.74 | 31.85 |
R1 | 31.92 | 32.10 |
R1 | 31.65 | 31.67 |
Average value | 31.79 | 32.06 |
Standard deviation | 0.12 | 0.21 |
CV value | 0.37% | 0.66% |
The above result shows that kit of the invention has good accuracy, high sensitivity, repeatability strong, easy to use
Feature is suitble to clinical use.
Comparative example 1
4 primer and probe sequence of table
Positive reference substance (i.e. the plasmid solution of the target fragment containing GD/Tv) is taken, its concentration is measured and calculates copy number, press
According to 10 times of concentration gradient dilution, 1.0 × 10 are chosen0~1.0 × 106Copy/μ L concentration is as sample, described in comparative example 1
Primer and probe detected.
The result shows that the primer and probe of comparative example 1 is that 100 copies/μ L (is equivalent to dense to the minimum detectability concentration of GD
Spend 10000 bacterium/mL), i.e., minimum detectability is 500 copies.Minimum detectability concentration to Tv is that 100 copies/μ L (is equivalent to
10000/mL of concentration), i.e., minimum detectability is 50 copies.The results show that the primer and probe reaction efficiency of comparative example 1 is inclined
Low, sensitivity is insufficient.
Embodiment 7: Amino-Cerv influences pattern detection
Selection common Amino-Cerv and cleaning product on the market, including anti-cervical erosion suppository, Nifuratel nystatin expandable vaginal soft capsule,
It is belle's health carbomer gel, the clean carbomer gel of cervicitis, ofloxacin gel, ofloxacin gel, metronidazole furanone bolt, clean
The negative washing lotion of that, is tested, its influence to kit detection is verified.
The result shows that 0.1mg/ml anti-cervical erosion suppository, 10mg/ml Nifuratel nystatin expandable vaginal soft capsule, 10mg/mL belle's health
Carbomer gel, the clean carbomer gel of 10mg/mL cervicitis, 10mg/mL ofloxacin gel, 10mg/mL metronidazole furanone bolt,
0.1% JIEERYIN XIYE can accurately detect to infect in drug with the presence or absence of GD or Tv to detection there is no interference.
The above is only a preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art
For member, various improvements and modifications may be made without departing from the principle of the present invention, these improvements and modifications are also answered
It is considered as protection scope of the present invention.
Sequence table
<110>Zhong Shengfang political affairs Biotechnology Ltd.
<120>primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method
<130> MP1916472
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 23
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 1
cggatcgtag tctgcaactc gac 23
<210> 2
<211> 24
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 2
tgctgcccac tttcatgact tgac 24
<210> 3
<211> 22
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
caccgcgacg ttgctgattc gc 22
<210> 4
<211> 25
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
caggttaatc tttgaatgca aattg 25
<210> 5
<211> 25
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 5
ttcctgcgta tggcagacta cgtgt 25
<210> 6
<211> 16
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 6
cccatgcttc tcgacc 16
<210> 7
<211> 25
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 7
tctgactcct gaggagaagt ctgcc 25
<210> 8
<211> 26
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 8
catgcccagt ttctattggt ctcctt 26
<210> 9
<211> 24
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 9
ccttgcccca cagggcagta acgg 24
<210> 10
<211> 127
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 10
cggatcgtag tctgcaactc gactacgtga aggcggagtc gctagtaatc gcgaatcagc 60
aacgtcgcgg tgaatgcgtt cccgggcctt gtacacaccg cccgtcaagt catgaaagtg 120
ggcagca 127
<210> 11
<211> 153
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 11
caggttaatc tttgaatgca aattgcgcta aactcgatct cggtcgagaa gcatgggtgt 60
gacagtacta catcttttat aataattctt attctaagcg aataagtaaa taatatataa 120
gacaaacaac acgtagtctg ccatacgcag gaa 153
<210> 12
<211> 138
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 12
tctgactcct gaggagaagt ctgccgttac tgccctgtgg ggcaaggtga acgtggatga 60
agttggtggt gaggccctgg gcaggttggt atcaaggtta caagacaggt ttaaggagac 120
caatagaaac tgggcatg 138
Claims (10)
1. the primer of double check Gardner bacillus and trichomonas vaginalis, probe groups comprising:
The primer pair of nucleotide sequence shown in NO:1~2 SEQ ID, the probe of nucleotide sequence shown in SEQ ID NO:3;With
The primer pair of nucleotide sequence shown in NO:4~5 SEQ ID, the probe of nucleotide sequence shown in SEQ ID NO:6.
2. primer according to claim 1, probe groups, which is characterized in that
5 ' ends of the probe of nucleotide sequence shown in SEQ ID NO:3 are marked with fluorescent reporter group CY5, and 3 ' ends are marked with fluorescence
Quenching group BHQ3;
5 ' ends of the probe of nucleotide sequence shown in SEQ ID NO:6 are marked with fluorescent reporter group FAM, and 3 ' ends are marked with fluorescence
Quenching group MGB.
3. the kit of double check Gardner bacillus and trichomonas vaginalis comprising primer of any of claims 1 or 2, spy
Needle group.
4. kit according to claim 3, which is characterized in that further include to reference gene HBB detection primer pair and
Probe;
The nucleotide sequence of the primer pair for reference gene HBB detection is as shown in NO:10~11 SEQ ID;
The nucleotide sequence of the probe for reference gene HBB detection is as shown in SEQ ID NO:12.
5. kit according to claim 4, which is characterized in that the probe of nucleotide sequence shown in SEQ ID NO:12
5 ' ends are marked with fluorescent reporter group ROX, and 3 ' ends are marked with fluorescent quenching group BHQ2.
6. kit according to claim 3, which is characterized in that further include fluorescence quantitative PCR detection reagent and/or sample
Extract reagent;
The fluorescence quantitative PCR detection reagent includes that qPCR Master Mix enzyme mixation, qPCR Master Mix reaction are slow
Fliud flushing;
The sample extraction reagent includes NaOH, TritonX-100 and TE buffer.
7. kit according to claim 3, which is characterized in that further include positive control and/or negative control;
Negative controls of the invention are DEPC water;
Positive reference substance of the invention is the plasmid solution containing Gardner bacillus and trichomonas vaginalis target fragment.
8. the method for detecting and distinguishing Gardner bacillus and trichomonas vaginalis characterized by comprising
With the described in any item kits of claim 3~7, real-time fluorescence quantitative PCR detection is carried out to sample to be tested DNA, is produced
Raw S type amplification curve is then positive.
9. according to the method described in claim 8, it is characterized in that, the system of the real-time fluorescence quantitative PCR includes:
10. according to the method described in claim 8, it is characterized in that, the program of the real-time fluorescence quantitative PCR includes:
50 DEG C 2 minutes;
95 DEG C of 5 minutes initial denaturations;
95 DEG C 15 seconds → 60 DEG C 35 seconds, 45 circulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910631817.1A CN110343775A (en) | 2019-07-12 | 2019-07-12 | The primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910631817.1A CN110343775A (en) | 2019-07-12 | 2019-07-12 | The primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110343775A true CN110343775A (en) | 2019-10-18 |
Family
ID=68175266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910631817.1A Pending CN110343775A (en) | 2019-07-12 | 2019-07-12 | The primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110343775A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113136438A (en) * | 2021-05-14 | 2021-07-20 | 广东省农业科学院动物卫生研究所 | Nucleic acid molecule, PCR primer pair and kit for detecting avian trichomonas beta-tubulin gene |
CN113151308A (en) * | 2021-05-10 | 2021-07-23 | 广东省农业科学院动物卫生研究所 | Nucleic acid molecule, PCR primer pair and kit for detecting avian trichomonas TBP gene |
CN116179731A (en) * | 2023-03-31 | 2023-05-30 | 斯贝福(北京)生物技术有限公司 | Primer probe set and kit for detecting trichomonas muriaticus and detection method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120103801A (en) * | 2011-03-11 | 2012-09-20 | (주)팸메드 | Methods for simultaneously detecting sexually transmitted disease-inducible microorganisms |
CN102719529A (en) * | 2012-05-04 | 2012-10-10 | 辽宁科骏生物有限公司 | Trichomonas vaginalis and candida albicans two-channel fluorescence PCR detection method and kit thereof |
US20130288988A1 (en) * | 2012-02-20 | 2013-10-31 | Laboratory Corporation Of America Holdings | Diagnostic Methods and Markers for Bacterial Vaginosis |
CN107099618A (en) * | 2017-05-03 | 2017-08-29 | 上海速创诊断产品有限公司 | A kind of LAMP primer composition thing and its related application for being used to detect urogenital tract pathogenic microorganisms |
US20180044739A1 (en) * | 2010-01-22 | 2018-02-15 | Gen-Probe Incorporated | Oligonucleotides for use in determiniing the presence of trichomonas vaginalis in a sample |
CN109487013A (en) * | 2019-01-09 | 2019-03-19 | 中生方政生物技术股份有限公司 | Herpes simplex virus I-type and II type detection marker, primed probe are to, kit and detection method |
-
2019
- 2019-07-12 CN CN201910631817.1A patent/CN110343775A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180044739A1 (en) * | 2010-01-22 | 2018-02-15 | Gen-Probe Incorporated | Oligonucleotides for use in determiniing the presence of trichomonas vaginalis in a sample |
KR20120103801A (en) * | 2011-03-11 | 2012-09-20 | (주)팸메드 | Methods for simultaneously detecting sexually transmitted disease-inducible microorganisms |
US20130288988A1 (en) * | 2012-02-20 | 2013-10-31 | Laboratory Corporation Of America Holdings | Diagnostic Methods and Markers for Bacterial Vaginosis |
US20170183716A1 (en) * | 2012-02-20 | 2017-06-29 | Laboratory Corporation Of America Holdings | Diagnostic Methods and Markers for Bacterial Vaginosis |
CN102719529A (en) * | 2012-05-04 | 2012-10-10 | 辽宁科骏生物有限公司 | Trichomonas vaginalis and candida albicans two-channel fluorescence PCR detection method and kit thereof |
CN107099618A (en) * | 2017-05-03 | 2017-08-29 | 上海速创诊断产品有限公司 | A kind of LAMP primer composition thing and its related application for being used to detect urogenital tract pathogenic microorganisms |
CN109487013A (en) * | 2019-01-09 | 2019-03-19 | 中生方政生物技术股份有限公司 | Herpes simplex virus I-type and II type detection marker, primed probe are to, kit and detection method |
Non-Patent Citations (1)
Title |
---|
李自刚等: "《生物检测技术》", 中国轻工业出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113151308A (en) * | 2021-05-10 | 2021-07-23 | 广东省农业科学院动物卫生研究所 | Nucleic acid molecule, PCR primer pair and kit for detecting avian trichomonas TBP gene |
CN113136438A (en) * | 2021-05-14 | 2021-07-20 | 广东省农业科学院动物卫生研究所 | Nucleic acid molecule, PCR primer pair and kit for detecting avian trichomonas beta-tubulin gene |
CN113136438B (en) * | 2021-05-14 | 2023-08-08 | 广东省农业科学院动物卫生研究所 | Nucleic acid molecule, PCR primer pair and kit for detecting trichomonas fowl beta-tubulin gene |
CN116179731A (en) * | 2023-03-31 | 2023-05-30 | 斯贝福(北京)生物技术有限公司 | Primer probe set and kit for detecting trichomonas muriaticus and detection method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110343780A (en) | Gardner bacillus, the primer of Candida albicans and trichomonas vaginalis Multiple detection, probe groups, kit and detection method | |
CN109825615A (en) | Primer, probe, kit and the detection method of chlamydia trachomatis, gonococcus and urea substance Multiple detection | |
CN109487013A (en) | Herpes simplex virus I-type and II type detection marker, primed probe are to, kit and detection method | |
CN110343775A (en) | The primer of double check Gardner bacillus and trichomonas vaginalis, probe groups, kit and detection method | |
CN103409509B (en) | Group B streptococcus fluorescence PCR detection kit | |
CN102719529B (en) | Trichomonas vaginalis and candida albicans two-channel fluorescence PCR detection method and kit thereof | |
CN105420360A (en) | Kit for instantly detecting vaginitis pathogen gene | |
CN103866034A (en) | Multiple real-time fluorescence quantification PCR (polymerase chain reaction) detection kit and detection method for helicobacter pylori in gastric juice | |
CN110373485A (en) | A kind of ureaplasma urealyticum, three joint inspection kit of chlamydia trachomatis and gonococcus | |
CN103409508A (en) | Gonococcus/ureaplasma urealyticum/chlamydia trachomatis triple nucleic acid detection kit | |
CN108060268A (en) | The application method of the primer and probes of HPV parting detections, kit and kit | |
CN101608210B (en) | Quantitative detection kit for helicobacter pylori nucleic acid | |
CN110283921A (en) | Gardner bacillus, the primer of Candida albicans double check, probe groups, kit and detection method | |
CN104513854B (en) | A kind of pathogen nucleic acid and drug resistance gene detection kit and its application | |
CN105368946A (en) | Group B streptococcus nucleic acid assay kit based on PCR (polymerase chain reaction) fluorescent probe method | |
CN102952850B (en) | Real-time fluorescent quantitative PCR method used for detecting Mycobacterium tuberculosis, and primer, probe and kit thereof | |
CN108866164A (en) | The streptococcic detection method of B race and kit | |
CN109852715A (en) | A kind of kit of TaqMan probe method detection leptospira interrogans metalloprotease gene | |
RU2362808C1 (en) | Way of diagnostics of microbiota disbalance of various human biotopes and degree of its expression | |
CN110343777A (en) | Primer, probe groups, kit and the detection method of four kinds of vagina the urinary tract mycoplasma Multiple detections | |
CN100415900C (en) | Fluorescent quantitative PCR determination kit for Neisser | |
CN109487014B (en) | Herpes simplex virus II type detection marker, primer probe pair, kit and detection method | |
CN111471781A (en) | Triple detection primer group for gonococcus, chlamydia trachomatis and mycoplasma urealytium, product and application | |
CN103060453A (en) | Kit for detecting neisseria gonorrheae (NG) | |
Sampson et al. | Molecular characterisation and antibiogram of vaginal flora from students attending a tertiary institution in Port Harcourt, Rivers state, Nigeria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191018 |
|
RJ01 | Rejection of invention patent application after publication |